ATE473236T1 - Antigene von piscirickettsia salmonis und deren verwendung - Google Patents

Antigene von piscirickettsia salmonis und deren verwendung

Info

Publication number
ATE473236T1
ATE473236T1 AT04769622T AT04769622T ATE473236T1 AT E473236 T1 ATE473236 T1 AT E473236T1 AT 04769622 T AT04769622 T AT 04769622T AT 04769622 T AT04769622 T AT 04769622T AT E473236 T1 ATE473236 T1 AT E473236T1
Authority
AT
Austria
Prior art keywords
present
discloses
antigens
srs
vaccines
Prior art date
Application number
AT04769622T
Other languages
English (en)
Inventor
Michel Thiry
Ingrid Dheur
Original Assignee
Michel Thiry
Ingrid Dheur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE473236(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Michel Thiry, Ingrid Dheur filed Critical Michel Thiry
Application granted granted Critical
Publication of ATE473236T1 publication Critical patent/ATE473236T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Paper (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
AT04769622T 2003-10-07 2004-10-01 Antigene von piscirickettsia salmonis und deren verwendung ATE473236T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE20030743 2003-10-07
PCT/IB2004/003339 WO2005035558A2 (en) 2003-10-07 2004-10-01 Piscirickettsia salmonis antigens and use thereof

Publications (1)

Publication Number Publication Date
ATE473236T1 true ATE473236T1 (de) 2010-07-15

Family

ID=34430665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04769622T ATE473236T1 (de) 2003-10-07 2004-10-01 Antigene von piscirickettsia salmonis und deren verwendung

Country Status (9)

Country Link
US (1) US7754223B2 (de)
EP (1) EP1670818B1 (de)
AT (1) ATE473236T1 (de)
AU (1) AU2004279610B2 (de)
CA (1) CA2541464C (de)
DE (1) DE602004028029D1 (de)
DK (1) DK177141B1 (de)
NO (1) NO341223B1 (de)
WO (1) WO2005035558A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1794185A1 (de) * 2004-10-01 2007-06-13 Michel Thiry Antigene von piscirickettsia salmonis und deren verwendung
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
DE102007004303A1 (de) * 2006-08-04 2008-02-07 Osram Opto Semiconductors Gmbh Dünnfilm-Halbleiterbauelement und Bauelement-Verbund
WO2008076975A1 (en) 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
DE102007004304A1 (de) * 2007-01-29 2008-07-31 Osram Opto Semiconductors Gmbh Dünnfilm-Leuchtdioden-Chip und Verfahren zur Herstellung eines Dünnfilm-Leuchtdioden-Chips
AU2008337440B2 (en) * 2007-12-19 2013-05-02 Intervet International B.V. Vaccine antigens from Piscirickettsia salmonis
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
EP3266448B1 (de) * 2009-03-27 2022-02-16 Intervet International B.V. Impfstoffe in mikropartikelform zur oralen oder nasalen impfung und stärkung von tieren einschliesslich fischen
AU2010254235B2 (en) 2009-05-26 2015-04-02 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
BR112012018839B1 (pt) 2010-01-28 2020-04-14 Advanced Bionutrition Corp composição vítrea seca compreendendo um material bioativo
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
NO20100454A1 (no) * 2010-03-26 2011-09-27 Ewos Innovation As Forbindelse og sammensetning for kontroll av bakterier og virus
MX350047B (es) 2010-08-13 2017-08-24 Advanced Bionutrition Corp Composicion de estabilizacion de almacenamiento en seco para materiales biologicos.
US8420072B2 (en) * 2011-03-24 2013-04-16 The United States Of America, As Represented By The Secretary Of Agriculture Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine
WO2013084169A2 (en) * 2011-12-07 2013-06-13 Yanez Carcamo Alejandro Javier Novel broth medium and blood-free solid media for the culture of the fish pathogen piscirickettsia salmonis
WO2015071769A2 (en) * 2013-11-13 2015-05-21 University Of Oslo Outer membrane vesicles and uses thereof
EP3328215B1 (de) 2015-07-29 2021-07-07 Advanced BioNutrition Corp. Stabile trockene probiotische zusammensetzungen für spezielle diätverwendungen
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
CL2017003358A1 (es) * 2017-12-26 2018-06-22 Univ De Chile 50% Formulación de vacuna para peces en base a nanovesículas lipídicas, en especial, un proteoliposoma o cocleato, con actividad contra el síndrome rickettsial del salmón

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus
DK0712926T3 (da) 1994-10-18 2004-02-09 Akzo Nobel Nv Virus, der forårsager bugspytkirtelsygdom hos fisk
US20040086524A1 (en) 1999-09-17 2004-05-06 Kuzyk Michael A. Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy
AU3539401A (en) 2000-01-07 2001-07-16 Akzo Nobel N.V. Vaccine for prevention and/or prophylaxis of infectious salmon anaemia in fish
EP1282710B1 (de) 2000-03-11 2008-03-05 Novartis AG Fischimpstoff gegen piscirickettsia salmonis
CA2420543C (en) 2000-08-22 2013-04-02 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
DK1334197T3 (da) * 2000-11-11 2011-04-04 Univ Aberdeen Gær-afledt vaccine mod IPNV
CA2381708C (en) 2001-08-27 2011-10-18 Universidad Catolica De Valparaiso Immunogenic protein against piscirickettsia salmonis

Also Published As

Publication number Publication date
EP1670818A2 (de) 2006-06-21
US7754223B2 (en) 2010-07-13
NO341223B1 (no) 2017-09-18
WO2005035558A3 (en) 2005-10-13
EP1670818B1 (de) 2010-07-07
US20070207165A1 (en) 2007-09-06
AU2004279610A1 (en) 2005-04-21
CA2541464C (en) 2016-02-09
NO20062044L (no) 2006-07-07
AU2004279610B2 (en) 2010-02-25
DK177141B1 (da) 2012-02-06
WO2005035558A2 (en) 2005-04-21
CA2541464A1 (en) 2005-04-21
DE602004028029D1 (en) 2010-08-19
DK200600643A (da) 2006-05-05

Similar Documents

Publication Publication Date Title
DE602004028029D1 (en) Rwendung
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
MXPA05008340A (es) Microbios de vida libre modificados, composiciones de vacuna y metodos de uso de los mismos.
EP1917033A4 (de) Virusähnliche partikel als paramyxovirus-impfstoffe
EA200702374A1 (ru) Анти-il-6 антитела, композиции, способы их получения и применения
UY26783A1 (es) Antígenos de estreptococo.
CL2008003794A1 (es) Virus de la estomatitis vesicular geneticamente modificado (vsv) que comprende por lo menos una mutacion de aminoacido en una region de alguna de las proteinas m, g y l del virus; metodo para producirlo; composicion inmunogenica que lo comprende; metodo para adaptar un virus en un cultivo celular.
NO20034244D0 (no) Mikrobielt fôr for akvakultur og landbruk
MXPA05013526A (es) Secuencias de acido nucleico que codifican y composiciones que comprenden el peptido de senal de ige y/o il-15 y metodos para uso de los mismos.
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
BRPI0408779A (pt) uso de composições, composição imunogênica e kit
MXPA05005202A (es) Vacuna.
AR042968A1 (es) Anticuerpos de virus anti-dengue composiciones metodos y usos
EA200970731A1 (ru) Рекомбинантные антигены цитомегаловируса человека (hcmv)
DE602004027362D1 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
DE60218327D1 (de) Inaktivierte immunogene bakterielle ganzzell-zusammensetzungen
ATE520708T1 (de) Immunogenetische hiv-1 multi-klade, multivalente konstrukte und deren verwendung
DE60143810D1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
CY1109206T1 (el) gM- ΑΡΝΗΤΙΚΟΙ EHV-ΜΕΤΑΛΛΑΚΤΕΣ ΧΩΡΙΣ ΕΤΕΡΟΛΟΓΑ ΣΤΟΙΧΕΙΑ
CY1105947T1 (el) Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus
ATE447968T1 (de) Impfung mit immunisolierten und einen immunomodulator produzierenden zellen
TW200509964A (en) VP1 of foot-and-mouth disease virus
NO20081541L (no) Ny sjo-lus vaksine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties